DK1680096T3 - Hidtil ukendt formulering til retinoidholdige blöde gelatinekapsler - Google Patents

Hidtil ukendt formulering til retinoidholdige blöde gelatinekapsler

Info

Publication number
DK1680096T3
DK1680096T3 DK04790978T DK04790978T DK1680096T3 DK 1680096 T3 DK1680096 T3 DK 1680096T3 DK 04790978 T DK04790978 T DK 04790978T DK 04790978 T DK04790978 T DK 04790978T DK 1680096 T3 DK1680096 T3 DK 1680096T3
Authority
DK
Denmark
Prior art keywords
soft gelatin
retinoid
gelatin capsules
formulation
containing soft
Prior art date
Application number
DK04790978T
Other languages
English (en)
Inventor
Guenter Ditzinger
Bernhard Gabriel
Anne-Hortense Schmitt-Hoffmann
Lutz Wevelsiep
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34178692&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1680096(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of DK1680096T3 publication Critical patent/DK1680096T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK04790978T 2003-11-03 2004-10-28 Hidtil ukendt formulering til retinoidholdige blöde gelatinekapsler DK1680096T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03405788A EP1527774A1 (en) 2003-11-03 2003-11-03 New formulation for retinoid-containing soft gelatin capsules
PCT/EP2004/012208 WO2005048994A1 (en) 2003-11-03 2004-10-28 New formulation for retinoid-containing soft gelatin capsules

Publications (1)

Publication Number Publication Date
DK1680096T3 true DK1680096T3 (da) 2008-08-04

Family

ID=34178692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04790978T DK1680096T3 (da) 2003-11-03 2004-10-28 Hidtil ukendt formulering til retinoidholdige blöde gelatinekapsler

Country Status (21)

Country Link
US (6) US20050042278A1 (da)
EP (2) EP1527774A1 (da)
JP (1) JP4555827B2 (da)
KR (1) KR100856362B1 (da)
CN (1) CN100594894C (da)
AT (1) ATE392204T1 (da)
AU (1) AU2004290494B2 (da)
BR (1) BRPI0415634B8 (da)
CA (1) CA2541292C (da)
CY (1) CY1108184T1 (da)
DE (1) DE602004013178T2 (da)
DK (1) DK1680096T3 (da)
ES (1) ES2303956T3 (da)
MX (1) MXPA06003821A (da)
NO (1) NO339743B1 (da)
NZ (1) NZ546258A (da)
PL (1) PL1680096T3 (da)
PT (1) PT1680096E (da)
RU (1) RU2344810C2 (da)
SI (1) SI1680096T1 (da)
WO (1) WO2005048994A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
AU2002351644A1 (en) 2001-12-26 2003-07-15 Research In Motion Limited User interface and method of viewing unified communications events on a mobile device
US20080112987A1 (en) * 2006-11-10 2008-05-15 National Starch And Chemical Investment Holding Corporation Coating for oxygen sensitive materials
US20110280960A1 (en) * 2008-12-04 2011-11-17 Juris Rubens Thick pine needle extract composition for capsulation
AU2009352678B2 (en) * 2009-09-15 2015-05-21 Eluminex Biosciences (Suzhou) Limited Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
RU2622763C2 (ru) 2010-04-19 2017-06-19 Новелион Терапьютикс Инк. Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов
JP6576636B2 (ja) 2012-03-01 2019-09-18 ノベリオン セラピューティクス インコーポレイテッド 内因性レチノイド欠乏に関連する視覚障害における視覚機能を改善するための治療的計画および方法
CN102716103B (zh) * 2012-07-02 2013-12-18 西安力邦制药有限公司 2,2′,6,6′-四异丙基-4,4′-二联苯酚软胶囊制剂及其制备方法
WO2018060866A1 (en) * 2016-09-28 2018-04-05 Dr. Reddy’S Laboratories Limited Oral retinoid compositions
CN107157966B (zh) * 2017-06-14 2021-04-13 程刚 一种纳米包裹视黄醛祛痘凝胶及其制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
CN109512795A (zh) * 2018-12-24 2019-03-26 浙江安宝药业有限公司 维生素a软胶囊
CN112618509A (zh) * 2019-09-24 2021-04-09 重庆华邦制药有限公司 一种维a酸软胶囊及其制备方法
RU2744142C1 (ru) * 2019-12-06 2021-03-03 Общество с ограниченной ответственностью "Артлайф" Композиция для профилактики грибковых заболеваний
CN113332258A (zh) * 2021-06-30 2021-09-03 山东良福制药有限公司 维a酸硬胶囊及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
ES2140449T3 (es) * 1992-01-14 2000-03-01 Hisamitsu Pharmaceutical Co Reductor del nivel de colesterol.
KR100274101B1 (ko) * 1992-01-22 2000-12-15 프리돌린 클라우스너, 롤란드 비. 보레르 9-시스 레틴산을 함유하는 약제학적 조성물
CZ282548B6 (cs) * 1992-01-22 1997-08-13 F. Hoffmann-La Roche Ag Farmaceutický přípravek
CA2093577C (en) 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
KR0173445B1 (ko) * 1996-09-17 1999-02-01 이능희 화장료용 이중캡슐 및 이를 함유하는 화장료 조성물
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
KR20040031107A (ko) * 1997-11-12 2004-04-09 에프. 호프만-라 로슈 아게 레티노이드 길항제를 이용한 제2형 t-보조세포 중재면역질환의 치료
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US6468559B1 (en) * 2000-04-28 2002-10-22 Lipocine, Inc. Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
WO2001095856A2 (en) 2000-06-15 2001-12-20 Chaconne Nsi Co., Ltd. Urea derivative useful as an anti-cancer agent and process for preparing same
IN192188B (da) 2000-06-16 2004-03-13 Ranbaxy Lab Ltd
EP1201686B1 (en) * 2000-10-23 2006-07-19 Mitsubishi Gas Chemical Company, Inc. Methyl methacrylate syrup and production thereof

Also Published As

Publication number Publication date
DE602004013178D1 (de) 2008-05-29
EP1680096B1 (en) 2008-04-16
SI1680096T1 (sl) 2008-08-31
DE602004013178T2 (de) 2009-05-07
EP1527774A1 (en) 2005-05-04
AU2004290494B2 (en) 2008-06-19
PT1680096E (pt) 2008-06-16
AU2004290494A1 (en) 2005-06-02
BRPI0415634B8 (pt) 2021-05-25
EP1680096A1 (en) 2006-07-19
CN100594894C (zh) 2010-03-24
MXPA06003821A (es) 2006-06-14
NZ546258A (en) 2009-12-24
NO20061890L (no) 2006-05-26
US8697122B2 (en) 2014-04-15
KR100856362B1 (ko) 2008-09-04
JP4555827B2 (ja) 2010-10-06
RU2344810C2 (ru) 2009-01-27
US20110212170A1 (en) 2011-09-01
US20050042278A1 (en) 2005-02-24
US9084823B2 (en) 2015-07-21
RU2006119326A (ru) 2007-12-27
BRPI0415634A (pt) 2006-12-12
WO2005048994A1 (en) 2005-06-02
US20100136108A1 (en) 2010-06-03
PL1680096T3 (pl) 2008-09-30
CA2541292A1 (en) 2005-06-02
CA2541292C (en) 2010-09-14
ES2303956T3 (es) 2008-09-01
JP2007509890A (ja) 2007-04-19
US20160367488A1 (en) 2016-12-22
CY1108184T1 (el) 2014-02-12
NO339743B1 (no) 2017-01-30
ATE392204T1 (de) 2008-05-15
BRPI0415634B1 (pt) 2018-12-26
US9399023B2 (en) 2016-07-26
CN1874762A (zh) 2006-12-06
US20150265539A1 (en) 2015-09-24
US9084824B2 (en) 2015-07-21
US20140205661A1 (en) 2014-07-24
KR20060093721A (ko) 2006-08-25

Similar Documents

Publication Publication Date Title
CY1108184T1 (el) Νεο σκευασμα για καψουλες μαλακης ζελατινης που περιεχουν ενα ρετινοειδες
AR051237A1 (es) Sistema de capsula blanda sin gelatina
EP2279729A3 (en) Controlled release preparations
DE60326432D1 (de) Calciumhaltiger kaugummi mit mittiger füllung
ITBO20030062A1 (it) Capsula utilizzabile per la preparazione di una bevanda infusa.
CL2004000224A1 (es) Formulacion farmaceutica estable que comprende una inmunoglobulina, un tampon fosfato, un polisorbato y cloruro de sodio, metodo de preparacion y su uso.
ATE355896T1 (de) Mononuklear gefüllte mikrokapseln
ES2115060T3 (es) Microparticulas, procedimiento para su produccion, asi como la utilizacion de estas para finalidades de diagnostico.
AR052776A1 (es) Composiciones de tabletas de goma de mascar comprimidas que entran en efervescencia al ser masticadas
HUP0303272A3 (en) Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators, pharmaceutical compositions containing them and their use
DE69912262D1 (de) Retinolhaltiges arzneimittel kompatibel mit weichgelatinekapseln
DK1518796T3 (da) Emballeret fødevareprodukt
BRPI0509971A (pt) uma forma de dosagem farmacêutica, comprimido e método de preparação
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
NO20040614L (no) Preparater som inneholder konjugert linolalkohol.
BR0314787A (pt) Forma de dosagem de liberação modificada
RU2012112939A (ru) Ароматизированные капсулы
MXPA04001779A (es) Modulacion de almacenamiento de vitamina.
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
WO2005107709A3 (en) Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
WO2004010974A3 (en) Gelatin capsule exhibiting reduced cross-linking
DK1858494T3 (da) Hidtil ukendte blöde gelatinekapsler
ATE433673T1 (de) Zusammengesetztes essbares produkt mit glyceridöl
DK1847258T3 (da) Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thie-no[3,2-c]pyridin-derivater
AR022442A1 (es) Una composicion antitranspirante con cera microcristalina